| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
28,133 |
20,129 |
$797K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
2,853 |
2,274 |
$93K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
7,679 |
5,333 |
$77K |
| 99219 |
|
980 |
840 |
$55K |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
2,553 |
2,016 |
$43K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
515 |
454 |
$40K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
2,267 |
1,674 |
$31K |
| 99217 |
|
914 |
793 |
$29K |
| 99222 |
Initial hospital care, per day, moderate complexity |
463 |
400 |
$18K |
| 99225 |
|
610 |
524 |
$18K |
| 99238 |
Hospital discharge day management, 30 minutes or less |
605 |
515 |
$16K |
| 99232 |
Subsequent hospital care, per day, moderate complexity |
697 |
299 |
$15K |
| 20552 |
|
740 |
562 |
$11K |
| 36415 |
Collection of venous blood by venipuncture |
3,042 |
2,553 |
$9K |
| 71045 |
Radiologic examination, chest; single view |
814 |
704 |
$8K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
182 |
171 |
$7K |
| 99218 |
|
336 |
273 |
$6K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
264 |
223 |
$5K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
38 |
35 |
$3K |
| 93000 |
|
249 |
219 |
$3K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
72 |
67 |
$3K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
33 |
31 |
$2K |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
4,661 |
3,501 |
$2K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
33 |
26 |
$1K |
| 90686 |
|
102 |
79 |
$1K |
| 99396 |
Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years |
12 |
12 |
$1K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
107 |
92 |
$1K |
| 99308 |
Subsequent nursing facility care, per day, straightforward |
183 |
167 |
$1K |
| 20550 |
|
78 |
45 |
$987.63 |
| 90674 |
|
74 |
69 |
$911.47 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
798 |
638 |
$855.91 |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
12 |
12 |
$785.80 |
| J0290 |
Injection, ampicillin sodium, 500 mg |
760 |
621 |
$610.57 |
| G0008 |
Administration of influenza virus vaccine |
120 |
110 |
$287.39 |
| 99422 |
|
21 |
12 |
$286.44 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
12 |
12 |
$195.00 |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
265 |
220 |
$133.83 |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
18 |
16 |
$113.84 |
| G8427 |
Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications |
13,201 |
9,197 |
$61.86 |
| 81003 |
|
153 |
128 |
$57.91 |
| 3079F |
|
36 |
30 |
$0.25 |
| 3078F |
|
48 |
41 |
$0.25 |
| 3074F |
|
45 |
34 |
$0.24 |
| 1111F |
|
110 |
91 |
$0.13 |
| 3075F |
|
20 |
17 |
$0.13 |
| 3077F |
|
13 |
13 |
$0.12 |
| G8420 |
Bmi is documented within normal parameters and no follow-up plan is required |
1,913 |
1,444 |
$0.00 |
| G8510 |
Screening for depression is documented as negative, a follow-up plan is not required |
140 |
118 |
$0.00 |
| G8417 |
Bmi is documented above normal parameters and a follow-up plan is documented |
6,738 |
4,964 |
$0.00 |
| G8431 |
Screening for depression is documented as being positive and a follow-up plan is documented |
64 |
55 |
$0.00 |
| G0444 |
Annual depression screening, 5 to 15 minutes |
25 |
24 |
$0.00 |